india: India needs regulatory data protection to attract drug research: Novartis CEO
India ought to have a regulatory information safety system in place to draw basic drug analysis from main pharmaceutical firms ...
India ought to have a regulatory information safety system in place to draw basic drug analysis from main pharmaceutical firms ...
The Delhi Excessive Courtroom on Wednesday reserved the order on Natco Pharma's writ petition over the grant of a patent ...
Indian-origin CEO of Swiss pharmaceutical large Novartis Vasant (Vas) Narasimhan on Friday stated while you come from a special background ...
Dr. Reddy's on Friday mentioned it has entered into an settlement with Novartis to accumulate the cardiovascular model Cidmus in ...
Copyright © 2022 Asia Today.